FMR LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-12 08:41 am Sale | 2022-12-09 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 385,863 0.784% | -3,168,232 (-89.14%) | Filing |
| 2022-06-10 11:04 am Sale | 2022-06-09 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 3,554,095 7.304% | -3,293,182 (-48.09%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 6,847,277 14.346% | 394,513 (+6.11%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 6,452,764 15.079% | 2,371,797 (+58.12%) | Filing |